Vincent Doré
Vincent Doré
CSIRO eHealth - Biomedical Informatics Group – Medical Image Analysis Team
Verified email at csiro.au
Title
Cited by
Cited by
Year
High performance plasma amyloid-β biomarkers for Alzheimer’s disease
A Nakamura, N Kaneko, VL Villemagne, T Kato, J Doecke, V Doré, ...
Nature 554 (7691), 249-254, 2018
7662018
Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions
VL Villemagne, V Doré, SC Burnham, CL Masters, CC Rowe
Nature Reviews Neurology 14 (4), 225-236, 2018
2292018
In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease
VL Villemagne, S Furumoto, MT Fodero-Tavoletti, RS Mulligan, J Hodges, ...
European journal of nuclear medicine and molecular imaging 41 (5), 816-826, 2014
1702014
Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease
V Doré, VL Villemagne, P Bourgeat, J Fripp, O Acosta, G Chetélat, L Zhou, ...
JAMA neurology 70 (7), 903-911, 2013
1662013
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a …
SC Burnham, P Bourgeat, V Doré, G Savage, B Brown, S Laws, P Maruff, ...
The Lancet Neurology 15 (10), 1044-1053, 2016
1602016
Aβ-amyloid and tau imaging in dementia
VL Villemagne, V Dore, P Bourgeat, SC Burnham, S Laws, O Salvado, ...
Seminars in nuclear medicine 47 (1), 75-88, 2017
1102017
Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well‐characterized cohorts
RF Buckley, EC Mormino, RE Amariglio, MJ Properzi, JS Rabin, YY Lim, ...
Alzheimer's & Dementia 14 (9), 1193-1203, 2018
1002018
Comparison of MR-less PiB SUVR quantification methods
P Bourgeat, VL Villemagne, V Dore, B Brown, SL Macaulay, R Martins, ...
Neurobiology of aging 36, S159-S166, 2015
772015
Multisite study of the relationships between antemortem [11C]PIB‐PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology
R La Joie, N Ayakta, WW Seeley, E Borys, AL Boxer, C DeCarli, V Doré, ...
Alzheimer's & Dementia 15 (2), 205-216, 2019
742019
18 F-Florbetaben PET beta-amyloid binding expressed in Centiloids
CC Rowe, V Doré, G Jones, D Baxendale, RS Mulligan, S Bullich, ...
European journal of nuclear medicine and molecular imaging 44 (12), 2053-2059, 2017
562017
Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer’s disease
G Chételat, R Ossenkoppele, VL Villemagne, A Perrotin, B Landeau, ...
Brain 139 (9), 2528-2539, 2016
562016
Subjective memory complaints in APOE ɛ4 carriers are associated with high amyloid-β burden
MD Zwan, VL Villemagne, V Doré, R Buckley, P Bourgeat, R Veljanoski, ...
Journal of Alzheimer's Disease 49 (4), 1115-1122, 2016
542016
Robust NL-means filter with optimal pixel-wise smoothing parameter for statistical image denoising
V Doré, M Cheriet
IEEE Transactions on Signal Processing 57 (5), 1703-1716, 2008
542008
Standardized expression of 18F-NAV4694 and 11C-PiB β-amyloid PET results with the Centiloid Scale
CC Rowe, G Jones, V Doré, S Pejoska, L Margison, RS Mulligan, ...
Journal of Nuclear Medicine 57 (8), 1233-1237, 2016
512016
Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults
SM Laws, S Gaskin, A Woodfield, V Srikanth, D Bruce, PE Fraser, T Porter, ...
Scientific reports 7 (1), 1-11, 2017
482017
MR-Less Surface-Based Amyloid Assessment Based on 11C PiB PET
L Zhou, O Salvado, V Dore, P Bourgeat, P Raniga, SL Macaulay, D Ames, ...
PLoS One 9 (1), e84777, 2014
382014
Implementing the centiloid transformation for 11C-PiB and β-amyloid 18F-PET tracers using CapAIBL
P Bourgeat, V Doré, J Fripp, D Ames, CL Masters, O Salvado, ...
Neuroimage 183, 387-393, 2018
352018
En attendant centiloid
VL Villemagne, V Doré, P Yates, B Brown, R Mulligan, P Bourgeat, ...
Science Domain International, 2014
332014
Risk of Alzheimer’s disease in obstructive sleep apnea syndrome: amyloid-β and Tau imaging
A Elias, T Cummins, R Tyrrell, F Lamb, V Dore, R Williams, JV Rosenfeld, ...
Journal of Alzheimer's Disease 66 (2), 733-741, 2018
302018
Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer’s disease
S Amadoru, V Doré, CA McLean, F Hinton, CE Shepherd, GM Halliday, ...
Alzheimer's research & therapy 12 (1), 1-8, 2020
292020
The system can't perform the operation now. Try again later.
Articles 1–20